Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06701071 · ClinicalTrials.gov registry record · Phase 4
Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation
A Phase 4 study of Infertility, Female, sponsored by University of Southern California.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06701071: Recruiting Phase 4 study of Infertility, Female, sponsored by University of Southern California.
NCT06701071 is a Phase 4 study of Infertility, Female that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 120 participants, below the 376-participant average among 18 other Infertility, Female trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06701071, a Phase 4 study of Infertility, Female, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate a long Clomid protocol as compared to a 5-day Clomid protocol for ovarian stimulation in patients with diminished ovarian reserve undergoing ovarian stimulation for in-vitro fertilization. The aim of the long Clomid protocol is to intensify stimulation of the ovaries and reduce both cost and injection burden for patients. Participants will be randomized to receive the long Clomid protocol vs. the typical protocol involving Clomid only for 5 days followed by growth hormone-releasing hormone (GnRH) antagonist. The primary outcome the investigators will evaluate will be the number of mature eggs retrieved.
Primary Outcome
The number of mature oocytes retrieved at oocyte retrieval
Conditions Studied
Interventions
- DRUG Clomiphene Citrate
Study Locations (1)
California
- HRC Fertility - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2027-12 |
| Phase | Phase 4 |
What NCT06701071 shows while recruiting
NCT06701071 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 18 other Infertility, Female trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Infertility, Female appearing as the primary indexed condition, and to 1 intervention - of which Clomiphene Citrate is the first listed.
NCT06701071 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06701071 about?
NCT06701071 is a clinical study titled "Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation". The goal of this clinical trial is to evaluate a long Clomid protocol as compared to a 5-day Clomid protocol for ovarian stimulation in patients with diminished ovarian reserve undergoing ovarian stimulation for in-vitro fertilization. The aim of the long Clomid protocol is to intensify stimulation ...
What is the current status of trial NCT06701071?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2025-06-01. Estimated completion is 2027-12.
What conditions does trial NCT06701071 study?
This clinical trial studies the following conditions: Infertility, Female.
What interventions are being tested in trial NCT06701071?
The interventions under investigation include: Clomiphene Citrate (DRUG).
Who is sponsoring clinical trial NCT06701071?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06701071 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility, Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06701071's enrollment target sits among peer trials
120 8th of 18 higher than 11 of 18 other Infertility, Female trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infertility, Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessing Efficacy of Intravenous Acetaminophen for Perioperative Pain Control for Oocyte Retrieval
COMPLETED · Phase 4
-
Cabergoline Before or After Oocyte Collection for Follicular Resolution
COMPLETED · Phase 4
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial
RECRUITING · NA
-
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
RECRUITING · NA
-
PROspective Study of Mothers' and Infants' Social and Epidemiologic Determinants of Health
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI